Truqap can be a kinase inhibitor that works by blocking pathways that help the most cancers cells survive and mature, so cuts down most cancers growth. Truqap is from a category of medicines referred to as an AKT inhibitor. Truqap acquired FDA approval on November 17, 2023, soon after favourable https://danielo777zlv9.blogchaat.com/profile